Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro cytogenicity / chromosome aberration study in mammalian cells
Remarks:
Type of genotoxicity: chromosome aberration
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2006
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: according to EC Directive 92/69/EEC and Regulation EC/440/2008 guideline methods under GLP conditions

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Report date:
2006

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
GLP compliance:
yes
Type of assay:
in vitro mammalian chromosome aberration test

Test material

Constituent 1
Chemical structure
Reference substance name:
-
EC Number:
473-730-4
EC Name:
-
Cas Number:
928768-73-4
Molecular formula:
C13H28SO3
IUPAC Name:
1-Octanol reaction products with epichlorhydrin and 2-mercaptoethanol
Test material form:
liquid: viscous
Details on test material:
Batch number: 20074-10142005

Method

Species / strain
Species / strain / cell type:
Chinese hamster Ovary (CHO)
Test concentrations with justification for top dose:
Short Term Treatment Test - Experiment 1

Group Final Concentration of Test Material (µg/ml)
6(18)-hour without S9 0*, 10.31 ,20.63*, 41.25*, 82.5*, 123.75, 165, MMC 0.1 *
6(18)-hour with S9 0*, 20.63,41.25*, 82.5*, 165*, 247.5, 330, CP 5.0*


Continuous Treatment Test - Experiment 2 and Short Term

Group Final Concentration of Test Material (µg/ml)
24-hour 0*, 5.15, 10.31*, 20.63*, 30.94*, 41.25*, 82.5 MMC 0.05*
6(18)-hour with S9 0*, 10.31,20.63*, 41.25*, 82.5*, 165,247.5, CP 5.0*


* Dose levels selected for metaphase analysis
MMC = mitomycin C
CP = cyclophosphamide
Details on test system and experimental conditions:
The Chinese Hamster Lung (CHL, also known as CHL/IU) cell line, isolated by Koyama et al (1970) and cloned by Ishidate and Sofbni (1985), was used. The CHL cell line has an average generation time of approximately 17 hours when growing under normal experimental conditions.

Cells were grown in Eagle's Minimal Essential Medium (MEM) with HEPES buffer and Earle's Salts and supplemented "in-house" with 10% foetal bovine serum and antibiotics, at 37°C with 5% C02 in air.

Cultures were established 16 to 72 hours prior to treatment using the appropriate number of cells per flask depending on the pre-exposure culture period. The cells were exposed to at least three doses of the test material, vehicle and positive controls both with and without metabolic activation. All exposures were performed in duplicate (A + B) and cultures were maintained at 37°C in a humidified atmosphere of 5% C02 in air.
Statistics:
The frequency of cells with aberrations excluding gaps and the frequency of polyploid cells was compared, where necessary, with the concurrent vehicle control value using Fisher's Exact test.

Results and discussion

Test results
Key result
Species / strain:
mammalian cell line, other: Chinese Hamster Lung (CHL, also known as CHL/IU)
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Positive controls validity:
valid

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information):
negative

The test material did not induce any statistically significant, dose-related increases in the frequency of cells with structural or numerical chromosome aberrations either in the presence or absence of a liver enzyme metabolising system or after various exposure times. The test material was therefore considered to be non-clastogenic to CHL cells in vitro.
Executive summary:

The test material did not induce any statistically significant, dose-related increases in the frequency of cells with structural or numerical chromosome aberrations either in the presence or absence of a liver enzyme metabolising system or after various exposure times. The test material was therefore considered to be non-clastogenic to CHL cells in vitro.